Join to View Full Profile
300 Pasteur Dr RM A343Stanford, CA 94305
Phone+1 650-723-6469
Dr. Sha is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sharon Sha is a neurologist in Palo Alto, CA and is affiliated with Stanford Health Care. She received her medical degree from Georgetown University School of Medicine and has been in practice 11 years. She specializes in movement disorder and dementia & geriatrics and is experienced in alzheimer's disease, lewy body dementia, ataxia, huntington disease, and geriatrics / dementia.
Education & Training
University of California (San Francisco)Fellowship, Behavioral Neurology, 2010 - 2013
Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 2008 - 2010
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 2007 - 2008
Sutter Health/California Pacific Medical CenterInternship, Internal Medicine, 2006 - 2007
Georgetown University School of MedicineClass of 2006
Certifications & Licensure
CA State Medical License 2008 - 2028
American Board of Psychiatry and Neurology Neurology
United council of neurological sub specialtiesbehavioral neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort Start of enrollment: 2012 Jul 01
- Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02) Start of enrollment: 2012 Jul 01
- Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019) Start of enrollment: 2013 Nov 05
- Join now to see all
Publications & Presentations
PubMed
- A phase 2 randomized, placebo-controlled study on the efficacy and safety of AR1001, a phosphodiesterase-5 inhibitor, in patients with mild-to-moderate Alzheimer's dis...David Greeley, Marshall Nash, Brad Herskowitz, Fred Kim, James Rock
The Journal of Prevention of Alzheimer's Disease... 2025-11-01 - 2 citationsAmyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts.Julien Lagarde, Piyush Maiti, Daniel R Schonhaut, Ganna Blazhenets, Jiaxiuxiu Zhang
Annals of Neurology. 2025-08-01 - Synergistic effects ofε4 and Alzheimer's pathology on the neural correlates of episodic remembering in cognitively unimpaired older adults.Alexandra N Trelle, Jintao Sheng, Edward N Wilson, America Romero, Jennifer Park
Biorxiv. 2025-06-25
Journal Articles
- Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration StudyLu Tian, Gayle K Deutsch, Geoffrey A Kerchner, Sharon J Sha, JAMA
Press Mentions
Bruce Willis Has a Rare Form of Dementia, Family AnnouncesFebruary 17th, 2023- Ask Me Anything: Brain Health and CognitionJune 23rd, 2022
Neurologist: The Brain Is Complicated, Largely UnknownMay 11th, 2020- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
